✦ LIBER ✦

Intranasal Insulin- And Biomarker-associated Improvement in Memory and Functional Status in Mild Cognitive Impairment and Alzheimer's Disease: Results of a Randomized, Double-blind, Placebo-controlled Pilot Trial

✍ Scribed by Craft, Suzanne; Baker, Laura D.; Montine, Thomas J.; Zhang, Jing; Watson, G. Stennis; Plymate, Stephen; Tsai, Elaine; Callaghan, Maureen; Leverenz, James; Gerton, Brooke; Trittschuh, Emily

Book ID: 121921697
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 48 KB
Volume: 6
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2010.08.054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of omega-3 fatty acids monot

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study

✍ Chih-Chiang Chiu; Kuan-Pin Su; Tsung-Chi Cheng; Hsing-Cheng Liu; Ching-Jui Chang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 450 KB

P4-337: Dimebon improves cognition, func

P4-337: Dimebon improves cognition, function, and behavior in mild and moderate Alzheimer's disease: Results by severity of a one-year, double-blind, placebo-controlled study

✍ Doody, Rachelle S.; Gavrilova, Svetlana; Thomas, Ronald; Aisen, Paul; Bachurin, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Cognitive and neuroendocrine response to

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo-controlled, double-blind, pilot study

✍ Sanjay Asthana; Suzanne Craft; Laura D Baker; Murray A Raskind; Roger S Birnbaum 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB

A 6-month, randomized, double-blind, pla

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

✍ D.P. Devanand; Gregory H. Pelton; Karine Cunqueiro; Harold A. Sackeim; Karen Mar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

## Abstract ## Objective In patients with Alzheimer's disease (AD) with psychosis or agitation that respond to haloperidol treatment, to evaluate the risk of relapse following discontinuation. ## Methods In outpatients with AD with symptoms of psychosis or agitation, responders to 20 weeks of ha

A randomized, double-blind placebo-contr

A randomized, double-blind placebo-controlled trial of simvastatin on CSF, MRI, and cognitive biomarkers in middle-aged adults at risk for Alzheimer's disease: The ESPRIT Study

✍ Cynthia M. Carlsson; Carey E. Gleason; Sterling C. Johnson; Guofan Xu; Yin Huang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 68 KB

A multi-center, randomized, double blind

A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics

✍ Tsai, W.-Y.; Cross, P.; Sano, M.; Jacobs, D.; Andrews, H.; Bell, K.; Graff-Radfo 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 155 KB